(Q41070207)

English

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Noel Jean Milpied

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

E Brissot

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Rialland

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Strullu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

N Corradini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Thomas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

N Blin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

X Rialland

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

E Thebaud

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Chevallier

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Moreau

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J L Harousseau

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Mechinaud

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Mohty

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

7 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

267-272

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26642337%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripher

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Indications for hematopoietic cell transplantation in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

How I treat EBV lymphoproliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Clinical implications of FLT3 mutations in pediatric AML.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.250

21 January 2018

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26642337

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41070207&oldid=2204246019"